343 related articles for article (PubMed ID: 30231374)
1. Integrating Genomics Into Neuro-Oncology Clinical Trials and Practice.
Galanis E; Nassiri F; Coy S; Nejad R; Zadeh G; Santagata S
Am Soc Clin Oncol Educ Book; 2018 May; 38():148-157. PubMed ID: 30231374
[TBL] [Abstract][Full Text] [Related]
2. [Selected biomarkers in the primary tumors of the central nervous system: short review].
Rychlý B; Grossmann P; Steňo A; Pataky F
Cesk Patol; 2012 Apr; 48(2):65-71. PubMed ID: 22716052
[TBL] [Abstract][Full Text] [Related]
3. Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community.
Aldape K; Nejad R; Louis DN; Zadeh G
Neuro Oncol; 2017 Mar; 19(3):336-344. PubMed ID: 27688263
[TBL] [Abstract][Full Text] [Related]
4. Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.
Ramkissoon LA; Britt N; Guevara A; Whitt E; Severson E; Sathyan P; Gay L; Elvin J; Ross JS; Brown C; Stogner-Underwood K; Mott R; Kram D; Strowd R; Lesser GJ; Ramkissoon SH
Curr Treat Options Oncol; 2018 Jun; 19(8):41. PubMed ID: 29931654
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
Gritsch S; Batchelor TT; Gonzalez Castro LN
Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
[TBL] [Abstract][Full Text] [Related]
6. Copy number assessment in the genomic analysis of CNS neoplasia: An evidence-based review from the cancer genomics consortium (CGC) working group on primary CNS tumors.
Neill SG; Hauenstein J; Li MM; Liu YJ; Luo M; Saxe DF; Ligon AH
Cancer Genet; 2020 May; 243():19-47. PubMed ID: 32203924
[TBL] [Abstract][Full Text] [Related]
7. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care.
Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G
Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041
[TBL] [Abstract][Full Text] [Related]
8. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
Fuller CE; Jones DTW; Kieran MW
Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
[TBL] [Abstract][Full Text] [Related]
9. Precision Medicine for Primary Central Nervous System Tumors: Are We There Yet?
Ippen FM; Colman H; van den Bent MJ; Brastianos PK
Am Soc Clin Oncol Educ Book; 2018 May; 38():158-167. PubMed ID: 30231322
[TBL] [Abstract][Full Text] [Related]
10. Shedding Light on the 2016 World Health Organization Classification of Tumors of the Central Nervous System in the Era of Radiomics and Radiogenomics.
Colen RR; Hassan I; Elshafeey N; Zinn PO
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):741-749. PubMed ID: 27742114
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Neuro-Oncology.
Malbari F
Neurol Clin; 2021 Aug; 39(3):829-845. PubMed ID: 34215389
[TBL] [Abstract][Full Text] [Related]
12. Applications of Genomic Sequencing in Pediatric CNS Tumors.
Bavle AA; Lin FY; Parsons DW
Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
[TBL] [Abstract][Full Text] [Related]
13. Management of Central Nervous System Tumors.
Kaley T; Nabors LB
J Natl Compr Canc Netw; 2019 May; 17(5.5):579-582. PubMed ID: 31117044
[TBL] [Abstract][Full Text] [Related]
14. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Nabors LB; Portnow J; Ahluwalia M; Baehring J; Brem H; Brem S; Butowski N; Campian JL; Clark SW; Fabiano AJ; Forsyth P; Hattangadi-Gluth J; Holdhoff M; Horbinski C; Junck L; Kaley T; Kumthekar P; Loeffler JS; Mrugala MM; Nagpal S; Pandey M; Parney I; Peters K; Puduvalli VK; Robins I; Rockhill J; Rusthoven C; Shonka N; Shrieve DC; Swinnen LJ; Weiss S; Wen PY; Willmarth NE; Bergman MA; Darlow SD
J Natl Compr Canc Netw; 2020 Nov; 18(11):1537-1570. PubMed ID: 33152694
[TBL] [Abstract][Full Text] [Related]
15. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.
Weller M; van den Bent M; Preusser M; Le Rhun E; Tonn JC; Minniti G; Bendszus M; Balana C; Chinot O; Dirven L; French P; Hegi ME; Jakola AS; Platten M; Roth P; Rudà R; Short S; Smits M; Taphoorn MJB; von Deimling A; Westphal M; Soffietti R; Reifenberger G; Wick W
Nat Rev Clin Oncol; 2021 Mar; 18(3):170-186. PubMed ID: 33293629
[TBL] [Abstract][Full Text] [Related]
16. Advances in the molecular genetics of gliomas - implications for classification and therapy.
Reifenberger G; Wirsching HG; Knobbe-Thomsen CB; Weller M
Nat Rev Clin Oncol; 2017 Jul; 14(7):434-452. PubMed ID: 28031556
[TBL] [Abstract][Full Text] [Related]
17. Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice.
Chukwueke UN; Wen PY
CNS Oncol; 2019 Mar; 8(1):CNS28. PubMed ID: 30806082
[No Abstract] [Full Text] [Related]
18. Advances in the management of primary central nervous system lymphoma.
Dunleavy K
Clin Adv Hematol Oncol; 2017 Sep; 15(9):677-679. PubMed ID: 28949937
[No Abstract] [Full Text] [Related]
19. Diagnostic and prognostic molecular markers in common adult gliomas.
Rivera AL; Pelloski CE
Expert Rev Mol Diagn; 2010 Jul; 10(5):637-49. PubMed ID: 20629512
[TBL] [Abstract][Full Text] [Related]
20. Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.
Juratli TA; Jungk C; Miller JJ
J Neurooncol; 2023 May; 162(3):457-459. PubMed ID: 37212938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
